In this talk Roger discusses the history and current status of using cell based therapies to repair the brain in patients with Parkinson’s Disease (PD). This includes our own work with fetal dopamine cell therapies as well as our planned trial using stem cell derived dopamine neurons.
Text: Cambridge Neuroscience
Roger Barker is the Professor of Clinical Neuroscience at the University of Cambridge and Consultant Neurologist at the Addenbrooke’s Hospital Cambridge. He is a PI in the MRC -Wellcome Trust Stem Cell Institute in Cambridge and Director of the MRC funded UKRMP Stem and Engineered cell hub. His research seeks to better define the clinical heterogeneity of two common neurodegenerative disorders of the CNS – namely Parkinson’s (PD) and Huntington’s disease (HD).
The Cambridge Neuroscience Interdisciplinary Seminar series is open to both members of the University, external academics and members of the public. We have tried to reflect the diversity of people’s interests at the University with our programme, and the breadth of the research taking place in Cambridge. Registration and more details on the series are available here: http://talks.cam.ac.uk/show/index/125…
For more information on Cambridge Neuroscience, please see http://www.neuroscience.cam.ac.uk or follow us on Twitter @CamNeuro
The STEM-PD Clinical Trial 